SURVIVAL OF PATIENTS WITH MALIGNANT-MELANOMA RECEIVING BCG WITH OR WITHOUT CHEMOTHERAPY

被引：0

作者：

GREEN, MD ^{[1
]}

MACKAY, IR ^{[1
]}

BUCKLEY, JC ^{[1
]}

COATES, AS ^{[1
]}

机构：

[1] ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,CLIN RES UNIT,MELBOURNE 3050,VICTORIA,AUSTRALIA

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1979年 / 49卷 / 03期

关键词：

D O I：

10.1111/j.1445-2197.1979.tb07675.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：335 / 339

页数：5

共 50 条

[31] REGIONAL CHEMOTHERAPY FOR MALIGNANT-MELANOMA
HAFSTROM, L
MATTSSON, J
CANCER TREATMENT REVIEWS, 1993, 19 (01) : 17 - 28
[32] MALIGNANT-MELANOMA - LOCAL CHEMOTHERAPY
PETTAVEL, J
PATHOLOGIE BIOLOGIE, 1990, 38 (08): : 870 - 871
[33] SYSTEMIC CHEMOTHERAPY FOR MALIGNANT-MELANOMA
COATES, AS
WORLD JOURNAL OF SURGERY, 1992, 16 (02) : 277 - 281
[34] DTIC CHEMOTHERAPY OF MALIGNANT-MELANOMA
ZAUMSEIL, RP
FIEDLER, H
LUBBE, D
DERMATOLOGISCHE MONATSSCHRIFT, 1977, 163 (11): : 905 - 914
[35] CYCLOCYTIDINE CHEMOTHERAPY FOR MALIGNANT-MELANOMA
MCKELVEY, EM
HEWLETT, JS
THIGPEN, T
WHITECAR, J
CANCER TREATMENT REPORTS, 1978, 62 (03): : 469 - 471
[36] CHEMOTHERAPY FOR ADVANCED MALIGNANT-MELANOMA
BUZAID, AC
MURREN, J
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1992, 21 (03): : 205 - 209
[37] CHEMOTHERAPY FOR DISSEMINATED MALIGNANT-MELANOMA
CHAUVERGNE, J
CLAVEL, B
KLEIN, T
POMMATAU, E
NOUVELLE PRESSE MEDICALE, 1978, 7 (30): : 2658 - 2659
[38] BCG PLUS PROTEASE I IN MALIGNANT-MELANOMA
MCILVANIE, SK
LANCET, 1973, 2 (7821): : 148 - 148
[39] INTRAVENOUS BCG AND DTIC FOR DISSEMINATED MALIGNANT-MELANOMA
GOODNIGHT, JE
CALLERY, C
KAGAN, RA
MORTON, DL
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 363 - 363
[40] TREATMENT OF MALIGNANT-MELANOMA BY INTRATUMORAL INJECTION OF BCG
PINSKY, C
HIRSHAUT, Y
OETTGEN, H
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 21 - &